Literature DB >> 25742804

A study of whether automated Diabetic Retinopathy Image Assessment could replace manual grading steps in the English National Screening Programme.

Venediktos V Kapetanakis1, Alicja R Rudnicka2, Gerald Liew3, Christopher G Owen2, Aaron Lee4, Vern Louw4, Louis Bolter5, John Anderson5, Catherine Egan4, Sebastian Salas-Vega6, Caroline Rudisill6, Paul Taylor7, Adnan Tufail4.   

Abstract

OBJECTIVES: Diabetic retinopathy screening in England involves labour intensive manual grading of digital retinal images. We present the plan for an observational retrospective study of whether automated systems could replace one or more steps of human grading.
METHODS: Patients aged 12 or older who attended the Diabetes Eye Screening programme, Homerton University Hospital (London) between 1 June 2012 and 4 November 2013 had macular and disc-centred retinal images taken. All screening episodes were manually graded and will additionally be graded by three automated systems. Each system will process all screening episodes, and screening performance (sensitivity, false positive rate, likelihood ratios) and diagnostic accuracy (95% confidence intervals of screening performance measures) will be quantified. A sub-set of gradings will be validated by an approved Reading Centre. Additional analyses will explore the effect of altering thresholds for disease detection within each automated system on screening performance.
RESULTS: 2,782/20,258 diabetes patients were referred to ophthalmologists for further examination. Prevalence of maculopathy (M1), pre-proliferative retinopathy (R2), and proliferative retinopathy (R3) were 7.9%, 3.1% and 1.2%, respectively; 4749 (23%) patients were diagnosed with background retinopathy (R1); 1.5% were considered ungradable by human graders.
CONCLUSIONS: Retinopathy prevalence was similar to other English diabetic screening programmes, so findings should be generalizable. The study population size will allow the detection of differences in screening performance between the human and automated grading systems as small as 2%. The project will compare performance and economic costs of manual versus automated systems.
© The Author(s) 2015.

Entities:  

Mesh:

Year:  2015        PMID: 25742804     DOI: 10.1177/0969141315571953

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  8 in total

1.  Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application.

Authors:  Valentina Bellemo; Gilbert Lim; Tyler Hyungtaek Rim; Gavin S W Tan; Carol Y Cheung; SriniVas Sadda; Ming-Guang He; Adnan Tufail; Mong Li Lee; Wynne Hsu; Daniel Shu Wei Ting
Journal:  Curr Diab Rep       Date:  2019-07-31       Impact factor: 4.810

2.  Teleophthalmology image-based navigated retinal laser therapy for diabetic macular edema: a concept of retinal telephotocoagulation.

Authors:  Igor Kozak; John F Payne; Patrik Schatz; Eman Al-Kahtani; Moritz Winkler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-26       Impact factor: 3.117

3.  Leveraging uncertainty information from deep neural networks for disease detection.

Authors:  Christian Leibig; Vaneeda Allken; Murat Seçkin Ayhan; Philipp Berens; Siegfried Wahl
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

4.  Sensitivity and specificity of automated analysis of single-field non-mydriatic fundus photographs by Bosch DR Algorithm-Comparison with mydriatic fundus photography (ETDRS) for screening in undiagnosed diabetic retinopathy.

Authors:  Pritam Bawankar; Nita Shanbhag; S Smitha K; Bodhraj Dhawan; Aratee Palsule; Devesh Kumar; Shailja Chandel; Suneet Sood
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

5.  Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence.

Authors:  Ramachandran Rajalakshmi; Radhakrishnan Subashini; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Eye (Lond)       Date:  2018-03-09       Impact factor: 3.775

Review 6.  Different fundus imaging modalities and technical factors in AI screening for diabetic retinopathy: a review.

Authors:  Gilbert Lim; Valentina Bellemo; Yuchen Xie; Xin Q Lee; Michelle Y T Yip; Daniel S W Ting
Journal:  Eye Vis (Lond)       Date:  2020-04-14

7.  Health Economic and Safety Considerations for Artificial Intelligence Applications in Diabetic Retinopathy Screening.

Authors:  Yuchen Xie; Dinesh V Gunasekeran; Konstantinos Balaskas; Pearse A Keane; Dawn A Sim; Lucas M Bachmann; Carl Macrae; Daniel S W Ting
Journal:  Transl Vis Sci Technol       Date:  2020-04-13       Impact factor: 3.283

8.  Clinical validation of an artificial intelligence-based diabetic retinopathy screening tool for a national health system.

Authors:  José Tomás Arenas-Cavalli; Ignacio Abarca; Maximiliano Rojas-Contreras; Fernando Bernuy; Rodrigo Donoso
Journal:  Eye (Lond)       Date:  2021-01-11       Impact factor: 3.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.